Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, abrdn Life Sciences Investors's average Book Value per Share Growth Rate was 34.50% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 3.80% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -4.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 9 years, the highest 3-Year average Book Value per Share Growth Rate of abrdn Life Sciences Investors was 3.80% per year. The lowest was -9.50% per year. And the median was -2.20% per year.
abrdn Life Sciences Investors (NYSE:HQL) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
abrdn Life Sciences Investors 3-Year Book Growth Rate Related Terms
HQL vs IIM, NOAH, FAX: 3-Year Book Growth Rate Comparison
For the Asset Management subindustry, abrdn Life Sciences Investors's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Life Sciences Investors 3-Year Book Growth Rate vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where abrdn Life Sciences Investors's 3-Year Book Growth Rate falls into.
abrdn Life Sciences Investors 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 3.80% mean?
abrdn Life Sciences Investors (HQL) has a 3-Year Book Growth Rate of 3.80% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for abrdn Life Sciences Investors and its competitors. According to the industry distribution chart, abrdn Life Sciences Investors ranks #635 out of 1536 companies in the Asset Management industry, placing it in the top 41.3%.
Is abrdn Life Sciences Investors' 3-Year Book Growth Rate too high?
abrdn Life Sciences Investors' current 3-Year Book Growth Rate is 3.80%. The Asset Management industry median 3-Year Book Growth Rate is 2.10. abrdn Life Sciences Investors' value of 3.80% is 81% above this industry median. Based on the distribution chart, abrdn Life Sciences Investors ranks #635 out of 1536 companies in the Asset Management industry, which is above the industry midpoint. Overall, abrdn Life Sciences Investors has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does abrdn Life Sciences Investors' 3-Year Book Growth Rate compare to IIM and NOAH?
According to the Asset Management industry distribution chart, abrdn Life Sciences Investors ranks #635 out of 1536 companies for 3-Year Book Growth Rate. This puts abrdn Life Sciences Investors in the upper half of its industry. The industry median 3-Year Book Growth Rate is 2.10. abrdn Life Sciences Investors' value of 3.80% is 81% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for an Asset Management company?
The median 3-Year Book Growth Rate among Asset Management companies is 2.10, based on 1,536 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Life Sciences Investors's current 3-Year Book Growth Rate of 3.80% is 81% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for abrdn Life Sciences Investors and its competitors. For the Asset Management industry, the median 3-Year Book Growth Rate is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Life Sciences Investors's current 3-Year Book Growth Rate is 3.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Life Sciences Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Life Sciences Investors (HQL) is currently considered Significantly Undervalued. The stock's GF Value™ is $62.01, compared to a current price of $22.08 — trading 64.4% below its estimated fair value. The current 3-Year Book Growth Rate is 3.80% and 81% above the Asset Management industry median of 2.10. abrdn Life Sciences Investors' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For abrdn Life Sciences Investors (HQL), the current 3-Year Book Growth Rate is 3.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Life Sciences Investors (HQL) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Life Sciences Investors stock appears to be undervalued.
The current stock price of $22.08 is trading 64.4% below its estimated GF Value™ of $62.01.
GuruFocus considers abrdn Life Sciences Investors to be Significantly Undervalued.
Key valuation signals for HQL:
3-Year Book Growth Rate: 3.80%
GF Value™: $62.01 vs. price of $22.08 (64.4% below fair value)
Industry Position: 81% above the Asset Management median (#635 of 1536)
No single metric tells the full story. See the HQL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
51GF Score
Get the complete analysis for HQL
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQL has been successfully added to your 
